XML 103 R86.htm IDEA: XBRL DOCUMENT v3.24.2.u1
SUBSEQUENT EVENTS (Details Narrative) - USD ($)
1 Months Ended 12 Months Ended
Mar. 21, 2024
Jul. 30, 2024
Jul. 19, 2024
Jun. 27, 2024
Jan. 23, 2024
Dec. 31, 2023
Dec. 31, 2022
Apr. 22, 2024
Gross proceeds from share sold           $ 0 $ 6,000,000  
Common stock, par value           $ 0.001 $ 0.001  
Subsequent Events [Member]                
Purchase price for the acquisition amounted         $ 637,080,000,000      
Consideration share         280,000      
Fair value of shares         $ 319,200      
Settelment amount         317,880      
Intangible asset         $ 637,080      
Common stock share sold 901,488              
Gross proceeds from share sold $ 648,893              
Common stock, par value               $ 0.001
Deadline report   Nasdaq further extended the filing deadline through October 14, 2024            
Subsequent Events [Member] | Pharmalink [Member]                
First purchase order       130,000        
First year purchase order       500,000        
Over year five purchase order       3,000,000        
Subsequent Events [Member] | Notification Letter [Member]                
Bid price     closing bid price of $1.00 or greater per common share for ten consecutive business days from July 5, 2024 to July 18, 2024          
Minimum bid price     $ 1.00          
Subsequent Events [Member] | Placement Agent [Member]                
Fees and other commissions 23,153              
Net proceeds $ 625,740